13F filer · CIK 1422848 ↗

Capital Research Global Investors

You are looking at Q4 2019. See the latest, Q2 2026 →

Reported value

$333.48B

+9.4% on the quarter before

Positions

405

23 new · 32 sold out

Top 10

29.6%

of the value

Est. gain

+$28.73B

on stocks held all quarter

Est. return

+10.1%

on those stocks since Q3 2019

Filed

Feb 18, 2020

On SEC EDGAR ↗

Positions as of Dec 31, 2019, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 47% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2019. Striped tiles are options.

Meta4.5%Microsoft4.4%Netflix3.7%
Abbott Laboratories3.0%
Unitedhealth Group Inc2.6%
Broadcom2.6%
Amgen Inc2.6%
Abbvie Inc2.3%
Amazon2.3%Alibaba1.8%
Gilead Sciences Inc1.7%
Mastercard1.6%
Eog Resources Inc1.5%
Exxon Mobil Corp1.4%
Alphabet1.3%
General Dynamics Corp1.2%
Csx Corp1.2%
Alphabet1.2%
Jpmorgan Chase And Co1.2%
Thermo Fisher Scientific Inc1.1%
Home Depot Inc1.1%
Intel1.0%
Philip Morris International1.0%
Linde Plc1.0%

Largest buys

Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Unitedhealth Group Inc~$2.13BAdded · 1.6% → 2.6%+7,261,158 shares
  2. Boeing Co~$879.4MAdded · 0.2% → 0.4%+2,699,641 shares
  3. Netflix~$877.9MAdded · 3.1% → 3.7%+2,713,207 shares
  4. Eog Resources Inc~$869.7MAdded · 1.2% → 1.5%+10,383,669 shares
  5. Wells Fargo And Co~$741.0MAdded · 0.1% → 0.3%+13,773,468 shares
  6. Enbridge Inc~$701.4MAdded · 0.0% → 0.2%+17,641,163 shares
  7. Alcon Inc~$621.4MAdded · 0.4% → 0.5%+10,970,060 shares
  8. Crown Castle Intl Corp (Reit)~$607.4MAdded · 0.4% → 0.6%+4,273,280 shares
  9. Gilead Sciences Inc~$542.2MAdded · 1.6% → 1.7%+8,343,863 shares
  10. Diamondback Energy Inc~$500.7MAdded · 0.4% → 0.5%+5,391,907 shares

Largest sells

Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Fidelity National Information Svs Inc~$1.35BCut · 1.0% → 0.5%−9,727,139 shares
  2. Nike Inc Cl B~$1.26BCut · 1.0% → 0.6%−12,439,256 shares
  3. Abbvie Inc~$1.24BCut · 2.5% → 2.3%−14,011,979 shares
  4. Mcdonalds Corp~$1.15BCut · 0.8% → 0.3%−5,814,621 shares
  5. Texas Instruments~$1.03BCut · 0.7% → 0.3%−7,994,966 shares
  6. ServiceNow~$751.2MCut · 0.5% → 0.3%−2,660,847 shares
  7. 3m Company~$654.1MSold out · 0.2% → 0.0%−3,978,891 shares
  8. Lowes Companies Inc~$551.2MCut · 0.4% → 0.2%−4,602,567 shares
  9. Workday~$547.5MCut · 0.3% → 0.1%−3,329,386 shares
  10. Stryker Corp~$539.1MCut · 0.9% → 0.6%−2,568,110 shares

Holdings

As of Dec 31, 2019. Changes are in shares against Sep 30, 2019, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
MetaCOMMON STOCK · shares +0.6% · price +15.3%4.5%$15.01B+$1.98B
MicrosoftCOMMON STOCK · shares −0.1% · price +13.4%4.4%$14.63B+$1.73B
NetflixCOMMON STOCK · shares +7.7% · price +20.9%3.7%$12.30B+$1.97B
Abbott LaboratoriesCOMMON STOCK · shares +0.5% · price +3.8%3.0%$9.88B+$360.7M
Unitedhealth Group IncCOMMON STOCK · shares +32% · price +35.3%2.6%$8.78B+$1.73B
BroadcomCOMMON STOCK · shares −0.04% · price +14.5%2.6%$8.59B+$1.09B
Amgen IncCOMMON STOCK · shares +5.2% · price +24.6%2.6%$8.52B+$1.60B
Abbvie IncCOMMON STOCK · shares −14% · price +16.9%2.3%$7.67B+$1.11B
AmazonCOMMON STOCK · shares +0.6% · price +6.4%2.3%$7.51B+$452.5M
AlibabaCOMMON STOCK · shares +3.9% · price +26.8%1.8%$6.00B+$1.22B
Gilead Sciences IncCOMMON STOCK · shares +11% · price +2.5%1.7%$5.53B+$122.9M
MastercardCOMMON STOCK · shares +0.4% · price +9.9%1.6%$5.32B+$479.4M
Eog Resources IncCOMMON STOCK · shares +21% · price +12.9%1.5%$5.07B+$478.6M
Exxon Mobil CorpCOMMON STOCK · shares +7.6% · price −1.2%1.4%$4.63B−$51.2M
AlphabetCOMMON STOCK · shares −4.4% · price +9.7%1.3%$4.39B+$388.0M
General Dynamics CorpCOMMON STOCK · shares −11% · price −3.5%1.2%$4.11B−$148.7M
Csx CorpCOMMON STOCK · shares +3.3% · price +4.5%1.2%$3.92B+$162.1M
AlphabetCOMMON STOCK · shares −3.2% · price +9.7%1.2%$3.91B+$344.9M
Jpmorgan Chase And CoCOMMON STOCK · shares +7.4% · price +18.4%1.2%$3.86B+$559.4M
Thermo Fisher Scientific IncCOMMON STOCK · shares −2.0% · price +11.5%1.1%$3.83B+$396.4M
Home Depot IncCOMMON STOCK · shares −0.06% · price −5.9%1.1%$3.58B−$223.4M
IntelCOMMON STOCK · shares −6.5% · price +16.1%1.0%$3.43B+$476.2M
Philip Morris InternationalCOMMON STOCK · shares +2.0% · price +12.1%1.0%$3.36B+$354.8M
Linde PlcCOMMON STOCK · shares −3.8% · price +9.9%0.99%$3.31B+$299.0M
Coca-Cola CoCOMMON STOCK · shares −1.9% · price +1.7%0.98%$3.25B+$53.5M
Total · 405 positions100%$333.48B+$28.73B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2019 to Q4 2019: 382 stocks held throughout, up $28.73B (+10.1%).

  1. Meta+$1.98B+15%
  2. Netflix+$1.97B+21%
  3. Microsoft+$1.73B+13%
  4. Unitedhealth Group Inc+$1.73B+35%
  5. Amgen Inc+$1.60B+25%
  6. General Dynamics Corp−$148.7M−3%
  7. Constellation Brands Inc Cl A−$159.0M−8%
  8. Hasbro Inc−$187.6M−11%
  9. Home Depot Inc−$223.4M−6%
  10. Pagseguro Digital Ltd Cl A−$332.7M−26%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$800.00B$400.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$716.87B+11%SEC ↗
Q1 2026$644.56B+19%SEC ↗
Q4 2025$541.73B+2%SEC ↗
Q3 2025$532.97B+7%SEC ↗
Q2 2025$499.46B+9%SEC ↗
Q1 2025$459.90B−5%SEC ↗
Q4 2024$486.38B+1%SEC ↗
Q3 2024$481.14B+6%SEC ↗
Q2 2024$455.74B+3%SEC ↗
Q1 2024$441.98B+9%SEC ↗
Q4 2023$406.47B+12%SEC ↗
Q3 2023$363.16B−3%SEC ↗
Q2 2023$373.18B+7%SEC ↗
Q1 2023$350.40B+6%SEC ↗
Q4 2022$330.88B+9%SEC ↗
Q3 2022$304.37B−5%SEC ↗
Q2 2022$321.05B−21%SEC ↗
Q1 2022$405.10B−11%SEC ↗
Q4 2021$452.67B+6%SEC ↗
Q3 2021$428.65B−0%SEC ↗
Q2 2021$429.52B+5%SEC ↗
Q1 2021$408.71B+6%SEC ↗
Q4 2020$385.30B+16%SEC ↗
Q3 2020$333.11B+5%SEC ↗
Q2 2020$316.13B+24%SEC ↗
Q1 2020$254.90B−24%SEC ↗
Q4 2019$333.48B+9%SEC ↗
Q3 2019$304.85B−3%SEC ↗
Q2 2019$314.99B−0%SEC ↗
Q1 2019$315.45B+10%SEC ↗
Q4 2018$287.02B−17%SEC ↗
Q3 2018$344.02B−6%SEC ↗
Q2 2018$366.12B+4%SEC ↗
Q1 2018$351.43B+3%SEC ↗
Q4 2017$340.76B+3%SEC ↗
Q3 2017$331.24B+4%SEC ↗
Q2 2017$319.49B+1%SEC ↗
Q1 2017$317.04B+3%SEC ↗
Q4 2016$308.47B+2%SEC ↗
Q3 2016$302.53B+3%SEC ↗
Q2 2016$292.47B+1%SEC ↗
Q1 2016$290.06BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.